EUVIMEDObjevte EUVIMED
Crossref

Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol

Di Su, Rong-Yuan Wei, Zhi-Ming Yan, Guo-Hui Zhong, Xiang-Qing Qin, Shu-Tong Huang, Juan-Yue Long, Feng-Ling Zhang, Ping He, Zhong-Ji Chen, Ya-Qian Yan, Neng Jiang and 1 more

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14247 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2023. Written by Di Su and 12 co-authors. Institution: Department of Gastrointestinal Surgery, Guangxi Clinical Research Center for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, …. Major MEDLINE topics: Triterpenes, Antineoplastic Agents. Cited 1 times so far (Crossref); 24 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Celastrol has been identified as a potential candidate for anticancer drug development. In this study, 28 novel celastrol derivatives with C‐6 sulfhydryl substitution and 20‐substitution were designed and synthesized, and their antiproliferative activity against human cancer cells and non‐malignant human cells was evaluated, with cisplatin and celastrol being used as controls. The results showed that most of the derivatives had enhanced in vitro anticancer activity compared to the parent compound celastrol. Specifically, derivative 2f demonstrated the most potent inhibitory potential and selectivity against HOS with an IC 50 value of 0.82 μM. Our study provides new insights into the structure–activity relationship of celastrol and suggests that compound 2f may be a promising drug candidate for the treatment of osteosarcoma.

Subjects

MeSH terms (MEDLINE)

TriterpenesAntineoplastic AgentsHumansMolecular StructureDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationDose-Response Relationship, DrugCell Line, TumorDrug DesignPentacyclic Triterpenes

Author keywords

C-6 modificationanticancer drugcelastrolstructure-activity relationship

Substances

TriterpenesAntineoplastic AgentscelastrolPentacyclic Triterpenes

Authors and institutions

  • Department of Gastrointestinal Surgery, Guangxi Clinical Research Center for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, P.R. China.
  • Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P.R. China.
  • College of Pharmacy, Guangxi Medical University, Nanning, P.R. China.
  • Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, P.R. China.

Cite

APA

Su, D., Wei, R. Y., Yan, Z. M., Zhong, G. H., Qin, X. Q., Huang, S. T., Long, J. Y., Zhang, F. L., He, P., Chen, Z. J., Yan, Y. Q., Jiang, N., & Tang, W. Z. (2023). Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14247

Vancouver

Su D, Wei RY, Yan ZM, Zhong GH, Qin XQ, Huang ST, et al. Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14247

BibTeX
@article{Su2023,
  author = {Su, Di and Wei, Rong-Yuan and Yan, Zhi-Ming and Zhong, Guo-Hui and Qin, Xiang-Qing and Huang, Shu-Tong and Long, Juan-Yue and Zhang, Feng-Ling and He, Ping and Chen, Zhong-Ji and Yan, Ya-Qian and Jiang, Neng and Tang, Wei-Zhong},
  title = {Design, synthesis, and evaluation of antitumor activity of novel C‐6 sulfhydryl‐substituted and 20‐substituted derivatives of celastrol},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14247}
}
Start for free →